256 related articles for article (PubMed ID: 18525392)
1. Cost-effectiveness of cardiac rehabilitation program delivery models in patients at varying cardiac risk, reason for referral, and sex.
Papadakis S; Reid RD; Coyle D; Beaton L; Angus D; Oldridge N
Eur J Cardiovasc Prev Rehabil; 2008 Jun; 15(3):347-53. PubMed ID: 18525392
[TBL] [Abstract][Full Text] [Related]
2. Impact of program duration and contact frequency on efficacy and cost of cardiac rehabilitation: results of a randomized trial.
Reid RD; Dafoe WA; Morrin L; Mayhew A; Papadakis S; Beaton L; Oldridge NB; Coyle D; Wells GA
Am Heart J; 2005 May; 149(5):862-8. PubMed ID: 15894969
[TBL] [Abstract][Full Text] [Related]
3. Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?
Oldridge N; Furlong W; Perkins A; Feeny D; Torrance GW
Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):608-15. PubMed ID: 18800005
[TBL] [Abstract][Full Text] [Related]
4. Long-term disease management of patients with coronary disease by cardiac rehabilitation program staff.
Squires RW; Montero-Gomez A; Allison TG; Thomas RJ
J Cardiopulm Rehabil Prev; 2008; 28(3):180-6; quiz 187-8. PubMed ID: 18496316
[TBL] [Abstract][Full Text] [Related]
5. The incremental cost effectiveness of in-patient versus out-patient rehabilitation after total hip arthroplasty - results of a pilot investigation.
Krummenauer F; Günther KP; Witzlebf WC
Eur J Med Res; 2008 Jun; 13(6):267-74. PubMed ID: 18558552
[TBL] [Abstract][Full Text] [Related]
6. Home-based cardiac rehabilitation versus hospital-based rehabilitation: a cost effectiveness analysis.
Taylor RS; Watt A; Dalal HM; Evans PH; Campbell JL; Read KL; Mourant AJ; Wingham J; Thompson DR; Pereira Gray DJ
Int J Cardiol; 2007 Jul; 119(2):196-201. PubMed ID: 17084927
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of pravastatin for primary prevention of coronary artery disease in Japan.
Nagata-Kobayashi S; Shimbo T; Matsui K; Fukui T
Int J Cardiol; 2005 Sep; 104(2):213-23. PubMed ID: 16168816
[TBL] [Abstract][Full Text] [Related]
8. Spinal cord stimulation versus reoperation for failed back surgery syndrome: a cost effectiveness and cost utility analysis based on a randomized, controlled trial.
North RB; Kidd D; Shipley J; Taylor RS
Neurosurgery; 2007 Aug; 61(2):361-8; discussion 368-9. PubMed ID: 17762749
[TBL] [Abstract][Full Text] [Related]
9. Economic evaluation of coronary artery bypass grafting surgery with and without cardiopulmonary bypass: cost-effectiveness and quality-adjusted life years in a randomized controlled trial.
Al-Ruzzeh S; Epstein D; George S; Bustami M; Wray J; Ilsley C; Sculpher M; Amrani M
Artif Organs; 2008 Nov; 32(11):891-7. PubMed ID: 18959683
[TBL] [Abstract][Full Text] [Related]
10. Cost-utility of a cardiovascular prevention program in highly educated adults: intermediate results of a randomized controlled trial.
Jacobs N; Evers S; Ament A; Claes N
Int J Technol Assess Health Care; 2010 Jan; 26(1):11-9. PubMed ID: 20059776
[TBL] [Abstract][Full Text] [Related]
11. Patterns and predictors of uptake and adherence to cardiac rehabilitation.
Sharp J; Freeman C
J Cardiopulm Rehabil Prev; 2009; 29(4):241-7. PubMed ID: 19628988
[TBL] [Abstract][Full Text] [Related]
12. Impact of worksite wellness intervention on cardiac risk factors and one-year health care costs.
Milani RV; Lavie CJ
Am J Cardiol; 2009 Nov; 104(10):1389-92. PubMed ID: 19892055
[TBL] [Abstract][Full Text] [Related]
13. Comparative outcome one year after formal cardiac rehabilitation: the effects of a randomized intervention to improve exercise adherence.
Arrigo I; Brunner-LaRocca H; Lefkovits M; Pfisterer M; Hoffmann A
Eur J Cardiovasc Prev Rehabil; 2008 Jun; 15(3):306-11. PubMed ID: 18525385
[TBL] [Abstract][Full Text] [Related]
14. Physician management preferences for cardiac patients: factors affecting referral to cardiac rehabilitation.
Grace SL; Evindar A; Abramson BL; Stewart DE
Can J Cardiol; 2004 Sep; 20(11):1101-7. PubMed ID: 15457306
[TBL] [Abstract][Full Text] [Related]
15. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
Sorensen SV; Frick KD; Wade A; Simko R; Burge R
Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
[TBL] [Abstract][Full Text] [Related]
16. Economic evaluation of drug-eluting stents compared to bare metal stents using a large prospective study in Ontario.
Goeree R; Bowen JM; Blackhouse G; Lazzam C; Cohen E; Chiu M; Hopkins R; Tarride JE; Tu JV
Int J Technol Assess Health Care; 2009 Apr; 25(2):196-207. PubMed ID: 19331710
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular risk.
Greving JP; Buskens E; Koffijberg H; Algra A
Circulation; 2008 Jun; 117(22):2875-83. PubMed ID: 18506010
[TBL] [Abstract][Full Text] [Related]
18. Cost effectiveness of a smoking cessation program in patients admitted for coronary heart disease.
Quist-Paulsen P; Lydersen S; Bakke PS; Gallefoss F
Eur J Cardiovasc Prev Rehabil; 2006 Apr; 13(2):274-80. PubMed ID: 16575284
[TBL] [Abstract][Full Text] [Related]
19. Cost effectiveness of community-based physical activity interventions.
Roux L; Pratt M; Tengs TO; Yore MM; Yanagawa TL; Van Den Bos J; Rutt C; Brownson RC; Powell KE; Heath G; Kohl HW; Teutsch S; Cawley J; Lee IM; West L; Buchner DM
Am J Prev Med; 2008 Dec; 35(6):578-88. PubMed ID: 19000846
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of a mixed-gender aftercare program for substance abuse: decomposing measured and unmeasured gender differences.
Yeom HS; Shepard DS
J Ment Health Policy Econ; 2007 Dec; 10(4):207-19. PubMed ID: 18166831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
